rs267606895
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★★).
Frequency
Mitomap GenBank:
Absent
Consequence
ND5
missense
missense
Scores
Apogee2
Pathogenic
Clinical Significance
MELAS-/-LHON-/-Leigh-overlap-syndrome,MELAS
Conservation
PhyloP100: 6.87
Genes affected
ND5 (HGNC:7461): (mitochondrially encoded NADH dehydrogenase 5) Enables NADH dehydrogenase (ubiquinone) activity. Involved in mitochondrial electron transport, NADH to ubiquinone and mitochondrial respiratory chain complex I assembly. Part of mitochondrial respiratory chain complex I. Implicated in Leber hereditary optic neuropathy; Leigh disease; and MELAS syndrome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
No frequency data in Mitomap. Probably very rare.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ND5 | unassigned_transcript_4815 | c.709A>C | p.Ile237Leu | missense_variant | 1/1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|
Frequencies
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
We have no GnomAD4 genomes data on this position. Probably position not covered by the project.
Mitomap
MELAS-/-LHON-/-Leigh-overlap-syndrome,MELAS
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:3Uncertain:1
Revision: reviewed by expert panel
LINK: link
Submissions by phenotype
Leigh syndrome due to mitochondrial complex I deficiency Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2003 | - - |
MELAS syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2003 | - - |
Leber optic atrophy Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2003 | - - |
Mitochondrial disease Uncertain:1
Uncertain significance, reviewed by expert panel | curation | ClinGen Mitochondrial Disease Nuclear and Mitochondrial Variant Curation Expert Panel, ClinGen | Nov 13, 2023 | The m.13045A>C (p.M237L) variant in MT-ND5 has been reported in one individual with primary mitochondrial disease to date (PMID: 12509858), in a boy with migraine-like symptoms (dizziness, vomiting, photophobia), clonic seizures that developed into epilepsia partialis continua, bilateral optic atrophy, ophthalmoplegia, ataxia, and cognitive impairment. He also had elevated cerebrospinal fluid lactate (normal lactate in blood) and muscle biopsy showed mildly reduced complex I activity. His brain imaging findings were consistent with Leigh syndrome and mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS). The variant was present at 82% heteroplasmy in muscle and 13% in blood. The variant was absent in blood from his healthy mother (PM6_supporting). There are several occurrences in population databases (absent in gnomAD v3.1.2 and the Helix dataset; present in one individual in the MITOMAP GenBank sequences, 1/61168, 0.00163%). Although there are several occurrences, the frequency is still low (PM2_supporting). The computational predictor APOGEE gives a consensus rating of pathogenic with a score of 0.73 (Min=0, Max=1; score of 0.905 in APOGEE2), which predicts a damaging effect on gene function (PP3). There are no cybrids, supporting single fiber studies, or de novo occurrences reported for this variant. In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on November 13, 2023. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PM2_supporting, PM6_supporting, PP3. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Apogee2
Pathogenic
Hmtvar
Pathogenic
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
GERP RS
Varity_R
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at